The US FDA has approved Medtronic’s 780G for use with rapid-acting insulin and with Abbott’s type 2 diabetes-specific sensor.
McGill researchers have developed a diagnostic system capable of identifying bacteria—and determining which antibiotics can stop them—in just 36 minutes, a major advance in the global effort to curb ...
DZYNE Technologies has set a new endurance benchmark for high-altitude unmanned aircraft after its ...
L-Charge today closed a $10 million funding round, led by Ultra Capital and Founder Dmitry Lashin, to scale its ...
Wizz Air is exploring flights to the US, but low-cost transatlantic routes have a long history of failure. With the Airbus ...
DZYNE Technologies LLC (DZYNE) today announced a breakthrough in unmanned aerial system (UAS) performance as its flagship ULTRA Turbo completed a ...
Specifications have leaked for the OnePlus 16 well ahead of its likely late 2026 launch, and its display could be something ...